Which hedge funds own LIVN? LIVANOVA PLC, Q2 2026 13F holders
Healthcare · Open on the interactive board
4 of the hedge funds tracked by WhaleCreep disclosed a position in LIVN (LIVANOVA PLC) in their Q2 2026 13F filings, worth $63.6m in total. The largest holder by portfolio weight is Scopia Capital Management at 8.3% of its book. 4 exited: D. E. Shaw & Co, Farallon Capital Management, Maverick Capital.
4tracked managers holding
0opened this quarter
4exited this quarter
Which hedge funds hold LIVN? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Scopia Capital Management | Q2 2026 | 8.3% | $9.3m | 112,957 | -39% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $41.3m | 502,395 | -79% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $9.3m | 113,400 | -38% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $3.7m | 45,036 | 73% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| D. E. Shaw & Co | 0.0% | $1.7m |
| Farallon Capital Management | 0.0% | $381.4k |
| Maverick Capital | 0.1% | $956.2k |
| Tudor Investment | 0.1% | $1.4m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Greenlight Capital | Q4 2023 | 1.8% |
How has hedge fund ownership of LIVN changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $63.6m |
| Q1 2026 | 9 | $186.0m |
| Q4 2025 | 4 | $66.7m |
| Q3 2025 | 5 | $55.1m |
| Q2 2025 | 5 | $48.5m |
| Q1 2025 | 6 | $19.0m |
| Q4 2024 | 5 | $60.4m |
| Q3 2024 | 4 | $125.8m |
| Q2 2024 | 4 | $85.2m |
| Q1 2024 | 4 | $46.3m |
| Q4 2023 | 4 | $93.7m |
| Q3 2023 | 5 | $145.6m |
| Q2 2023 | 5 | $85.7m |
| Q1 2023 | 6 | $63.4m |
| Q4 2022 | 5 | $175.3m |
| Q3 2022 | 5 | $281.7m |
Counts every tracked manager that disclosed LIVN in that quarter's filing, including managers that have since stopped filing.